Skip to content

Influences of Phenylephrine, Dopamine and Ephedrine on Stroke Volume Variation and Pulse Pressure Variation

Influences of Phenylephrine, Dopamine and Ephedrine on Stroke Volume Variation and Pulse Pressure Variation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02201121
Enrollment
94
Registered
2014-07-25
Start date
2014-03-31
Completion date
2014-06-30
Last updated
2014-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calculated SAP, Circulation, Drug Dose

Brief summary

Although induced hypertension decreased SVV and PPV,the influences of stroke volume variation and pulse pressure variation caused by phenylephrine,dopamine and ephedrine were unknown.

Detailed description

Pulse pressure variation (PPV) and stroke volume variation (SVV) during mechanical ventilation have been shown to be effective parameters to predict preload responsiveness. Although induced hypertension decreases PPV and SVV, the influences of phenylephrine, dopamine and ephedrine on PPV and SVV are unknown.

Interventions

OTHERInfluences of phenylephrine, dopamine and ephedrine on stroke volume variation and pulse pressure variation

This research mainly study the effect of clinical commonly used vasoconstrictor drugs on blood pressure of pressure

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Their American Society of Anesthesiologists (ASA) physical status was 1 or 2 * Body mass index (BMI) ranged from 18 to 26 * None of the patients had known diabetes mellitus, hypertension, cardiovascular, pulmonary, endocrinological, neurological diseases, or diseases that influenced intravascular fluid volume or balance * All patients had a preoperative fast for at least 8 h and routine atropine intramuscular injection

Exclusion criteria

* Persistent arrhythmias * Intraoperative application of vasoactive drugs except phenylephrine, dopamine and ephedrine

Design outcomes

Primary

MeasureTime frameDescription
invasive arterial blood pressure as a Measure of SafetyDAY 1if instability of circulation, stop the clinical trial

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026